Clinical trials
Active, not recruiting Melanoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2020 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 2 |
| Novartis Pharmaceuticals | 2 |
| BeiGene | 1 |
| Hoffmann-La Roche | 1 |
| Pfizer | 1 |
| RemeGen Co., Ltd. | 1 |
| Shanghai Henlius Biotech | 1 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 10 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Carcinoma, Renal Cell | 7 |
| Colorectal Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Brain Neoplasms | 2 |
| Carcinoma, Transitional Cell | 2 |
| Head and Neck Neoplasms | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.